Baharudin Ibrahim

2.6k total citations
90 papers, 1.5k citations indexed

About

Baharudin Ibrahim is a scholar working on Molecular Biology, Cardiology and Cardiovascular Medicine and Physiology. According to data from OpenAlex, Baharudin Ibrahim has authored 90 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Molecular Biology, 19 papers in Cardiology and Cardiovascular Medicine and 14 papers in Physiology. Recurrent topics in Baharudin Ibrahim's work include Metabolomics and Mass Spectrometry Studies (19 papers), Antiplatelet Therapy and Cardiovascular Diseases (16 papers) and Asthma and respiratory diseases (9 papers). Baharudin Ibrahim is often cited by papers focused on Metabolomics and Mass Spectrometry Studies (19 papers), Antiplatelet Therapy and Cardiovascular Diseases (16 papers) and Asthma and respiratory diseases (9 papers). Baharudin Ibrahim collaborates with scholars based in Malaysia, United Kingdom and Bangladesh. Baharudin Ibrahim's co-authors include Mohitosh Biswas, Tapash Kumar Biswas, Stephen J. Fowler, Ashley Woodcock, Maria Basanta, David Douce, Abubakar Sha’aban, Dileep Kumar Singh, Paul Cadden and Muhamad Ali SK Abdul Kader and has published in prestigious journals such as SHILAP Revista de lepidopterología, Journal of the American College of Cardiology and Scientific Reports.

In The Last Decade

Baharudin Ibrahim

80 papers receiving 1.4k citations

Peers

Baharudin Ibrahim
Oscar Della Pasqua United Kingdom
M.G. Bissell United States
Ashish Kumar United States
Kara L. Lynch United States
Ping Du United States
Daniel González United States
Oscar Della Pasqua United Kingdom
Baharudin Ibrahim
Citations per year, relative to Baharudin Ibrahim Baharudin Ibrahim (= 1×) peers Oscar Della Pasqua

Countries citing papers authored by Baharudin Ibrahim

Since Specialization
Citations

This map shows the geographic impact of Baharudin Ibrahim's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Baharudin Ibrahim with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Baharudin Ibrahim more than expected).

Fields of papers citing papers by Baharudin Ibrahim

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Baharudin Ibrahim. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Baharudin Ibrahim. The network helps show where Baharudin Ibrahim may publish in the future.

Co-authorship network of co-authors of Baharudin Ibrahim

This figure shows the co-authorship network connecting the top 25 collaborators of Baharudin Ibrahim. A scholar is included among the top collaborators of Baharudin Ibrahim based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Baharudin Ibrahim. Baharudin Ibrahim is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Jairoun, Ammar Abdulrahman, Chee Ping Chong, & Baharudin Ibrahim. (2024). Predictors of chronic kidney disease survival in type 2 diabetes: a 12-year retrospective cohort study utilizing estimated glomerular filtration rate. Scientific Reports. 14(1). 9014–9014. 2 indexed citations
5.
Akkaif, Mohammed Ahmed, Nur Aizati Athirah Daud, Dzul Azri Mohamed Noor, et al.. (2024). The Impact of CYP2C19 Genotype on the Platelet Reactivity Index (PRI) among Chronic Coronary Syndromes (CCS) Patients Undergoing Percutaneous Coronary Intervention (PCI): Affectability of Rapid Genetic Testing. Cardiovascular Drugs and Therapy. 39(2). 347–356. 2 indexed citations
7.
Ali, Irfhan Ali Hyder, et al.. (2023). Chronic obstructive pulmonary disease and emerging ER stress-related therapeutic targets. Pulmonary Pharmacology & Therapeutics. 81. 102218–102218. 3 indexed citations
8.
Akkaif, Mohammed Ahmed, Nur Aizati Athirah Daud, Dzul Azri Mohamed Noor, et al.. (2023). Platelet reactivity index after treatment of clopidogrel versus ticagrelor based on CYP2C19 genotypes among patients undergoing percutaneous coronary intervention: results of a randomized study. European Heart Journal. 44(Supplement_1). 2 indexed citations
9.
Othman, Noordin, et al.. (2022). Adequacy of Empiric Antibiotics Therapy and Its Impact on Outcomes in Adult Critically Ill Sepsis Patients: A Review. Malaysian Journal of Medical Sciences. 29(5). 17–23. 5 indexed citations
10.
Sha’aban, Abubakar, Hadzliana Zainal, Ewe Seng Ch’ng, et al.. (2022). Prediction of Low-Dose Aspirin-Induced Gastric Toxicity Using Nuclear Magnetic Resonance Spectroscopy-Based Pharmacometabolomics in Rats. Molecules. 27(7). 2126–2126. 2 indexed citations
11.
Zainal, Hadzliana, et al.. (2021). Pharmacists’ Interventions on Electronic Prescriptions from Various Specialty Wards in a Malaysian Public Hospital: A Cross-Sectional Study. SHILAP Revista de lepidopterología. 9(4). 161–161. 4 indexed citations
12.
Akkaif, Mohammed Ahmed, Nur Aizati Athirah Daud, Abubakar Sha’aban, et al.. (2021). The Role of Genetic Polymorphism and Other Factors on Clopidogrel Resistance (CR) in an Asian Population with Coronary Heart Disease (CHD). Molecules. 26(7). 1987–1987. 45 indexed citations
13.
Akkaif, Mohammed Ahmed, Abubakar Sha’aban, Nur Aizati Athirah Daud, et al.. (2021). Coronary Heart Disease (CHD) in Elderly Patients: Which Drug to Choose, Ticagrelor and Clopidogrel? A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Journal of Cardiovascular Development and Disease. 8(10). 123–123. 17 indexed citations
14.
Ibrahim, Baharudin, et al.. (2021). Addressing the standardisation of internal standards and preservative used in human bio fluids for NMR analysis: a method optimization. Drug Metabolism and Personalized Therapy. 36(3). 189–197.
15.
Hassali, Mohamed Azmi, Baharudin Ibrahim, Bandana Saini, et al.. (2020). Translation and validation of the Test of Adherence to Inhalers (TAI) questionnaire among adult patients with asthma in Malaysia. Journal of Asthma. 58(9). 1229–1236. 12 indexed citations
16.
Akkaif, Mohammed Ahmed, Abubakar Sha’aban, Nur Aizati Athirah Daud, Mah Lee Ng, & Baharudin Ibrahim. (2020). Investigate the Strategy of Using Pharmacogenetics and Pharmacometabonomics to the Personalization of Ticagrelor Antiplatelet Therapy. Systematic Reviews in Pharmacy. 11(9). 1100–1107. 12 indexed citations
17.
Jaber, Ammar Ali Saleh & Baharudin Ibrahim. (2019). Health-related quality of life of patients with multidrug-resistant tuberculosis in Yemen: prospective study. Health and Quality of Life Outcomes. 17(1). 142–142. 22 indexed citations
19.
Wimmer, Barbara C., et al.. (2017). Incidence and pattern of medication errors in a general paediatric ward in a developing nation. Research in Social and Administrative Pharmacy. 14(3). 317–319. 5 indexed citations
20.
Seow, Eng‐Keng, Baharudin Ibrahim, Syahidah Akmal Muhammad, et al.. (2016). Discrimination between cave and house-farmed edible bird's nest based on major mineral profiles.. Pertanika journal of tropical agricultural science. 39(2). 181–196. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026